Soleno Therapeutics Inc. (SLNO) PT Raised to $110 at H.C. Wainwright

Go back to Soleno Therapeutics Inc. (SLNO) PT Raised to $110 at H.C. Wainwright

Baird on Soleno Therapeutics Inc. (SLNO): 'Buyers on pullback following short report'

August 19, 2025 5:12 AM EDT

Baird analyst Brian Skorney reiterated an Outperform rating and $121.00 price target on Soleno Therapeutics Inc. (NASDAQ: SLNO)

The analyst comments "Buyers on pullback following short report. The Soleno short report, published on Friday, claims Vykat is a ticking safety time bomb and... More